Delivery Order SPE2DB20D3104-SPE2DB24FV9D4

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,930.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,615,751 units of Fexofenadine HCL 180 mg tablets in 500-count bottles. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,061 firm-fixed-price delivery order is for the supply of 4,566,211,485 units of Fexofenadine HCL 180 mg tablets in 500-count containers, with a period of performance through October 28, 2024. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,544.01, is a Delivery Order for 4,566,970,272 units of Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,159.51, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,559.97 Firm Fixed Price delivery order contract is for the supply of 4,565,122,465 units of Fexofenadine HCL 180 mg tablets. The contract has a period of performance through July 12, 2024 and was awarded on July 11, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,184.35 Firm Fixed Price Delivery Order contract is for the supply of 4,567,019,980 tablets of Fexofenadine HCL 180 mg, with a completion date of January 24, 2025. The contract is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,606.53 Firm Fixed Price Delivery Order contract is for the supply of 4,559,577,420 units of Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of January 12, 2023 and was awarded on January 11, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,272,960 units of Fexofenadine HCL 180 mg tablets, a medication used to treat allergies. The contract has a ceiling value of $1,216.68 and a completion date of September 25, 2023. This contract is a delivery order and is priced as a firm-fixed price. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,564,993 units of Fexofenadine HCL 180 mg tablets. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, awarded to AmerisourceBergen by the DLA Troop Support Medical. The contract has a ceiling value of $3,369.04 and a completion date of June 26, 2024. There is no set-aside designation for this award. As a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $4,601.99, with a firm fixed-price pricing type and a completion date of March 12, 2024. The contract provides for the purchase of 4,563,925,315 units of Fexofenadine HCL 180 MG Tablets, a pharmaceutical product. Amerisourcebergen holds a significant Indefinite Delivery Contract...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB24FV9D4
    Delivery Order

This federal contract award, valued at $4,481.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,675,808 units of Fexofenadine HCL 180 mg Tablets, with a completion date of September 5, 2024.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 2/27/25, 10:56 AM